-
[New Year's Analysis] Korea’s next homegrown drug could be a first local CAR-T as payer keeps widening access
06 Jan 2026 08:58 GMT
… HIV maintenance regimen of Vocabria (cabotegravir) and Rekambys (rilpivirine) … and it cleared Mirum Pharmaceutical’s Livmarli (maralixibat) … control.
Time-to-treatment is another point Curocell … drugs, though those comparisons will depend on cross-trial …
-
China releases 4th batch of encouraged generic drugs in 21 varieties
04 Jan 2026 18:37 GMT
… batch of generic drugs list aimed at guiding pharmaceutical companies to research … to better meet patients' treatment needs, according to Xinhua.
To … of 34 encouraged generic medicines including anti-AIDS drugs Rilpivirine and Abacavir and leukemia …
-
73 drugs lost exclusivity in 2025
30 Dec 2025 02:12 GMT
In 2025, the FDA approved 73 first-time generic drugs.
Here are the … of approval date:
Note: The FDA’s information is current as … . Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablet — For treatment of HIV-1 infection …
-
<![CDATA[HIV in 2025 Defined by Challenges Throughout the Year, Despite Some Advances]]>
17 Dec 2025 00:01 GMT
… Plan for AIDS Relief (PEPFAR),3 stating that all … Cornell HIV Clinical Trials Unit at the Weill Cornell Medical College … of injectable cabotegravir and rilpivirine was approved as … ;healthcare-pharmaceuticals/;us-spells-out-life-saving-hiv-treatment-that- …
-
HIV Drugs Market to Exceed US $41.55 Billion by 2029, with 3.3% CAGR: The Business Research Company
10 Dec 2025 10:30 GMT
… the HIV drug market. HIV/AIDS … Emcure Pharmaceuticals
• Micro Labs Limited
• Northeast Pharmaceutical Group … treatment.
Comparative Analysis Of Leading HIV Drugs Market Segments
The hiv drugs … NVP), Etravirine (ETR), Rilpivirine (RPV), Other NNRTIs …
-
The Pathological Link Between Elevated Markers of Inflammation, Endothelial Activation, and Cardiovascular Diseases in People Living with HIV on Combination Antiretroviral Therapy: A Systematic Review
09 Dec 2025 16:29 GMT
… fumarate (TDF), (RAL), rilpivirine (RPV), or emtricitabine (FTC … use of these drugs with a statin drug such as … -Mural Postdoctoral and doctoral Fellowship Programme from … treatment with rosuvastatin in HIV-infected patients under antiretroviral therapy. AIDS …
-
How two-month HIV shots reduce pill burden
08 Dec 2025 06:52 GMT
… found that injectable HIV treatment, Cabotegravir/Rilpivirine, also known in medical terms as … -tolerated, and preferred by most HIV patients.
Results from the first … hope for adherence to HIV antiretroviral management, reduced HIV related deaths, and …
-
Two-month HIV shots reduce pill burden, study
08 Dec 2025 06:01 GMT
… injectable HIV treatment, Cabotegravir/Rilpivirine, also known in medical terms … study, a randomised controlled trial, concluded in October and … fewer side effects, fewer drug interactions, and a … the burden of daily pills, adherence becomes easier, …
-
Long-acting HIV treatment could improve outcomes for breastfeeding women
05 Dec 2025 02:55 GMT
… rilpivirine (CAB/RPV), can help women suppress the HIV … . Instead of daily oral pills, the injection is received … sustain treatment during the postpartum period and keep their medical … Preventing AIDS Complications (CEPAC) model to simulate how HIV is …
-
ACPN Demands Local Production Of HIV Drugs As Funding Cuts Threaten Nigeria’s AIDS Response
02 Dec 2025 12:54 GMT
… invest in local manufacturing of HIV drugs and commodities, warning that … to avoid major setbacks in HIV treatment and prevention.
“The recent … ,400 new HIV infections and 50,000 AIDS-related deaths … of Cabotegravir 600 mg and Rilpivirine 900 mg for eligible …